Name (Synonyms) | Correlation | |
---|---|---|
drug1482 | Isoprinosine Wiki | 1.00 |
drug1563 | Levamisole Wiki | 1.00 |
drug3179 | anti-SARS-CoV-2 plasma Wiki | 1.00 |
drug2122 | Placebo Wiki | 0.05 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This randomized open labeled clinical trial will include one hundred healthy healthcare workers who will be randomly assigned into four groups of twenty-five each to receive either levamisole, Isoprinosine, combined levamisole and isoprinosine or no-intervention for two months to detect the impact of Levamisole and Isoprinosine as immune-prophylaxis on the incidence of COVID-19 infection. Participants will be followed-up for three months clinically and laboratory. Blood samples will be collected prior to randomization and during follow up.
Description: Detect if Levamisole and Isoprinosine can decrease the incidence of COVID-19 infection
Measure: Decrease the incidence of COVID-19 infection or its severity Time: 6 months